Should a Lower Treatment Line Be Used When Treating Paracetamol Poisoning in Patients with Chronic Alcoholism?
- 1 January 2002
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 25 (9) , 619-624
Abstract
A lower threshold for treatment of paracetamol (acetaminophen) poisoning has been advocated in chronic heavy users of alcohol, based originally on animal studies indicating that chronic alcohol ingestion increased hepatotoxicity. This was attributed to increased production of the toxic metabolite, N-acetyl-p-benzoquinoneimine, by cytochrome P450 (CYP)2E1 induction. The clinical evidence for increased risk is limited to four retrospective studies with potential for referral and reporting bias and conflicting results. No study has specifically addressed the issue of the treatment threshold for acute paracetamol overdose in chronic alcohol users. However, animal studies in multiple species have consistently shown a lower dose of paracetamol is required to produce hepatotoxicity after chronic alcohol use. The knowledge of potential mechanisms has expanded to include effects of other alcohols, such as isopentanol, induction of CYP enzymes other than CYP2E1 and glutathione depletion. There are no convincing reasons or data to suggest these findings do not apply to humans. However, further human toxicokinetic and clinical research is required to quantify the extent of the interaction. Arguments about treating overdoses should not be confused with those about whether there is an alcohol-paracetamol interaction at therapeutic doses. Halving the threshold dose/concentration for treatment is a conservative educated guess that has been widely adopted. In overdose, the potential benefits of treatment at this lower threshold clearly outweigh the minimal risks of acetylcysteine.Keywords
This publication has 36 references indexed in Scilit:
- Reduction of Toxic Metabolite Formation of AcetaminophenBiochemical and Biophysical Research Communications, 2002
- Short-term Treatment with Alcohols Causes Hepatic Steatosis and Enhances Acetaminophen Hepatotoxicity in Cyp2e1(-/-) MiceToxicology and Applied Pharmacology, 2000
- Paracetamol hepatotoxicity and alcohol consumption in deliberate and accidental overdoseQJM: An International Journal of Medicine, 2000
- Paracetamol, alcohol and the liverBritish Journal of Clinical Pharmacology, 2000
- Role of CYP3A in Ethanol-Mediated Increases in Acetaminophen HepatotoxicityToxicology and Applied Pharmacology, 1997
- Risk assessment: toxicity from chemical exposure resulting from enhanced expression of CYP2E1Toxicology, 1995
- Recent Developments in the Management of Paracetamol (Acetaminophen) PoisoningDrug Safety, 1992
- Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen OverdoseNew England Journal of Medicine, 1988
- Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity.Gut, 1988
- Effects of Alcoholism on Acetaminophen Pharmacokinetics in ManThe Journal of Clinical Pharmacology, 1984